Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity - PubMed (original) (raw)
Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity
Matthew F Peters et al. J Biomol Screen. 2009 Mar.
Abstract
G-protein-coupled receptors can couple to different signal transduction pathways in different cell types (termed cell-specific signaling) and can activate different signaling pathways depending on the receptor conformation(s) stabilized by the activating ligand (functional selectivity). These concepts offer potential for developing pathway-specific drugs that increase efficacy and reduce side effects. Despite significant interest, functional selectivity has been difficult to exploit in drug discovery, in part due to the burden of multiple assays. Cellular impedance assays use an emerging technology that can qualitatively distinguish Gs, Gi/o, and Gq signaling in a single assay and is thereby suited for studying these pharmacological concepts. Cellular impedance confirmed cell-specific Gs and Gq coupling for the melanocortin-4 receptor and dual Gi and Gs signaling with the cannabinoid-1 (CB1) receptor. The balance of Gi versus Gs signaling depended on the cell line. In CB1-HEKs, Giand Gs-like responses combined to yield a novel impedance profile demonstrating the dynamic nature of these traces. Cellspecific signaling was observed with endogenous D1 receptor in U-2 cells and SK-N-MC cells, yet the pharmacological profile of partial and full agonists was similar in both cell lines. We conclude that the dynamic impedance profile encodes valuable relative signaling information and is sufficiently robust to help evaluate cell-specific signaling and functional selectivity.
Similar articles
- Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J, Venter DP, Brink CB. Bodenstein J, et al. J Pharmacol Exp Ther. 2005 Aug;314(2):891-905. doi: 10.1124/jpet.105.083568. Epub 2005 Apr 27. J Pharmacol Exp Ther. 2005. PMID: 15857948 - Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
Heydorn A, Ward RJ, Jorgensen R, Rosenkilde MM, Frimurer TM, Milligan G, Kostenis E. Heydorn A, et al. Mol Pharmacol. 2004 Aug;66(2):250-9. doi: 10.1124/mol.66.2.250. Mol Pharmacol. 2004. PMID: 15266015 - Comparing label-free biosensors for pharmacological screening with cell-based functional assays.
Peters MF, Vaillancourt F, Heroux M, Valiquette M, Scott CW. Peters MF, et al. Assay Drug Dev Technol. 2010 Apr;8(2):219-27. doi: 10.1089/adt.2009.0232. Assay Drug Dev Technol. 2010. PMID: 20085460 - Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors.
Schneider EH, Seifert R. Schneider EH, et al. Pharmacol Ther. 2010 Dec;128(3):387-418. doi: 10.1016/j.pharmthera.2010.07.005. Epub 2010 Aug 10. Pharmacol Ther. 2010. PMID: 20705094 Review. - Regulation of cell proliferation by G proteins.
Dhanasekaran N, Tsim ST, Dermott JM, Onesime D. Dhanasekaran N, et al. Oncogene. 1998 Sep 17;17(11 Reviews):1383-94. doi: 10.1038/sj.onc.1202242. Oncogene. 1998. PMID: 9779986 Review.
Cited by
- Biased agonism.
Kenakin T. Kenakin T. F1000 Biol Rep. 2009 Nov 26;1:87. doi: 10.3410/B1-87. F1000 Biol Rep. 2009. PMID: 20948603 Free PMC article. - GPCR systems pharmacology: a different perspective on the development of biased therapeutics.
Eiger DS, Pham U, Gardner J, Hicks C, Rajagopal S. Eiger DS, et al. Am J Physiol Cell Physiol. 2022 May 1;322(5):C887-C895. doi: 10.1152/ajpcell.00449.2021. Epub 2022 Feb 23. Am J Physiol Cell Physiol. 2022. PMID: 35196164 Free PMC article. Review. - Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
Paisdzior S, Dimitriou IM, Schöpe PC, Annibale P, Scheerer P, Krude H, Lohse MJ, Biebermann H, Kühnen P. Paisdzior S, et al. Int J Mol Sci. 2020 Feb 12;21(4):1224. doi: 10.3390/ijms21041224. Int J Mol Sci. 2020. PMID: 32059383 Free PMC article. - Adenosine receptors: Emerging non-opioids targets for pain medications.
Jung SM, Peyton L, Essa H, Choi DS. Jung SM, et al. Neurobiol Pain. 2022 Mar 25;11:100087. doi: 10.1016/j.ynpai.2022.100087. eCollection 2022 Jan-Jul. Neurobiol Pain. 2022. PMID: 35372716 Free PMC article. Review. - Gsα deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gsα mutations.
Chen M, Berger A, Kablan A, Zhang J, Gavrilova O, Weinstein LS. Chen M, et al. Endocrinology. 2012 Sep;153(9):4256-65. doi: 10.1210/en.2012-1113. Epub 2012 Jun 25. Endocrinology. 2012. PMID: 22733970 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources